- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ALNY
Recent news which mentions ALNY
What 16 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
September 12, 2023
Tickers
ALNY
From Benzinga
Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today
September 11, 2023
Tickers
ALNY
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
From Benzinga
Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public'
September 08, 2023
From Benzinga
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
From Benzinga
Here's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today
September 05, 2023
Tickers
ALNY
From Benzinga
From Benzinga
Lululemon Athletica To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
July 25, 2023
From Benzinga
From Benzinga
Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy
July 24, 2023
From Benzinga
Why Shares of BridgeBio Pharma Skyrocketed This Week
July 21, 2023
From Motley Fool
Why Alnylam Pharmaceuticals Topped the Market Today
July 17, 2023
From Motley Fool
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
From Benzinga
Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars
July 17, 2023
From Benzinga
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years
July 14, 2023
Tickers
ALNY
From Benzinga
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 10 Years
June 16, 2023
Tickers
ALNY
From Benzinga
From Benzinga
Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech
June 07, 2023
From Benzinga
From MarketWatch
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.